Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04993066 · ClinicalTrials.gov registry record · NA
Clinical Evaluation to Assess the Safety and Efficacy of GentleMax Pro Plus
A NA study, sponsored by Candela Corporation.
- Completed
- Registry status
- NA
- Development phase
- 77
- Enrollment target
NCT04993066 is a NA study that has completed, run by Candela Corporation. The registered enrollment target is 77 participants.
The verdict
NCT04993066, a NA study, has completed, sponsored by Candela Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 77 participants
- Enrollment target
Study Summary
Demonstrate the safety and efficacy of the GentleMax Pro Plus™ laser system for its intended uses: hair removal including pseudofolliculitis barbae (PFB), clearance of pigmented and/or vascular lesions, temporary increase of clear nail in patients with onychomycosis and improvement in appearance of wrinkles. Evaluate GentleMax Pro Plus™ laser system for the clearance of acne.
Interventions
- DEVICE GentleMax Pro Plus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2020-11-12 |
| Est. Completion | 2023-04-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04993066
The ClinicalTrials.gov registry entry for NCT04993066 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Candela Corporation, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GentleMax Pro Plus is the first listed.
NCT04993066 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04993066 about?
NCT04993066 is a clinical study titled "Clinical Evaluation to Assess the Safety and Efficacy of GentleMax Pro Plus". Demonstrate the safety and efficacy of the GentleMax Pro Plus™ laser system for its intended uses: hair removal including pseudofolliculitis barbae (PFB), clearance of pigmented and/or vascular lesions, temporary increase of clear nail in patients with onychomycosis and improvement in appearance of ...
What is the current status of trial NCT04993066?
This trial is currently completed. It is a NA study. The enrollment target is 77 participants. The study started on 2020-11-12. Estimated completion is 2023-04-27.
What interventions are being tested in trial NCT04993066?
The interventions under investigation include: GentleMax Pro Plus (DEVICE).
Who is sponsoring clinical trial NCT04993066?
This trial is sponsored by Candela Corporation, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.